Altered cerebral glucose utilization following blood-brain barrier opening by hypertonicity or hypertension.
D000818:Animals; D001089:Arabinose / Q000494:pharmacology; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003837:Deoxy Sugars / Q000378:metabolism*; D003847:Deoxyglucose / Q000378:metabolism*; D006973:Hypertension / Q000378:metabolism*; D008297:Male; D009994:Osmolar Concentration; D011188:Potassium / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000378:metabolism
D003837:Deoxy Sugars; D003847:Deoxyglucose; D012964:Sodium; D001089:Arabinose; D011188:Potassium